Technology

Since our founding, Agenus has pursued our principles of targeting the immune system to fight disease. Tumors evade detection and elimination by the immune system through various mechanisms.

Read More
Pipeline

Agenus is discovering and developing a broad range of innovative therapeutic antibodies and vaccines through our focused efforts to assemble a uniquely comprehensive arsenal of complementary technologies.

Read More
Collaborations

We are actively pursuing a variety of partnership opportunities to augment our internal programs.

Read More

Agenus is an immuno-oncology company driven by innovation and speed. Our goal is to treat cancers with novel combinations utilizing our unique portfolio of checkpoint antibodies, tumor microenvironment modifiers, vaccines and adjuvants. In addition to a broad portfolio, we have an accomplished team of scientists, novel technology platforms and fully-integrated end-to-end capabilities from discovery to GMP manufacturing. With our remarkable combination of science and people, we believe that we are uniquely positioned to bring curative treatments to cancer patients.

Our strategy involves combination approaches utilizing our unique portfolio of checkpoint antibodies, tumor microenvironment modifiers, vaccines and adjuvants. Read More